Intellia Therapeutics, Inc.
Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis

Last updated:

Abstract:

Compositions and methods for editing, e.g., introducing double-stranded breaks, within the TTR gene are provided. Compositions and methods for treating subjects having amyloidosis associated with transthyretin (ATTR), are provided.

Status:
Application
Type:

Utility

Filling date:

24 Mar 2020

Issue date:

6 Aug 2020